MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma BJ Gill, DJ Pisapia, HR Malone, H Goldstein, L Lei, A Sonabend, J Yun, ... Proceedings of the National Academy of Sciences 111 (34), 12550-12555, 2014 | 281 | 2014 |
A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies PD Chang, HR Malone, SG Bowden, DS Chow, BJA Gill, TH Ung, ... American Journal of Neuroradiology 38 (5), 890-898, 2017 | 106 | 2017 |
Multiscale recordings reveal the dynamic spatial structure of human seizures CA Schevon, S Tobochnik, T Eissa, E Merricks, B Gill, RR Parrish, ... Neurobiology of disease 127, 303-311, 2019 | 51 | 2019 |
Murine cell line model of proneural glioma for evaluation of anti-tumor therapies AM Sonabend, J Yun, L Lei, R Leung, C Soderquist, C Crisman, BJ Gill, ... Journal of neuro-oncology 112, 375-382, 2013 | 45 | 2013 |
Sodium fluorescein facilitates guided sampling of diagnostic tumor tissue in nonenhancing gliomas SG Bowden, JA Neira, BJA Gill, TH Ung, ZK Englander, G Zanazzi, ... Neurosurgery 82 (5), 719-727, 2018 | 39 | 2018 |
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial EF Spinazzi, MG Argenziano, PS Upadhyayula, MA Banu, JA Neira, ... The Lancet Oncology 23 (11), 1409-1418, 2022 | 25 | 2022 |
Local glioma cells are associated with vascular dysregulation SG Bowden, BJA Gill, ZK Englander, CI Horenstein, G Zanazzi, PD Chang, ... American Journal of Neuroradiology 39 (3), 507-514, 2018 | 17 | 2018 |
Fluorescein-guided resection of gliomas. AV Save, BJ Gill, RS D'amico, P Canoll, JN Bruce Journal of Neurosurgical Sciences 63 (6), 648-655, 2019 | 13 | 2019 |
Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states O Al-Dalahmah, MG Argenziano, A Kannan, A Mahajan, J Furnari, ... Nature Communications 14 (1), 2586, 2023 | 10 | 2023 |
Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex X Wu, AA Sosunov, W Lado, JJ Teoh, A Ham, H Li, O Al-Dalahmah, ... Cell reports 40 (3), 2022 | 10 | 2022 |
Neurosurgery case review: questions and answers R Nader, AJ Sabbagh Georg Thieme Verlag, 2020 | 9 | 2020 |
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas CJ Kinslow, AI Rae, K Taparra, P Kumar, MD Siegelin, J Grinband, ... Clinical Cancer Research 29 (21), 4399-4407, 2023 | 8 | 2023 |
Ex vivo multi-electrode analysis reveals spatiotemporal dynamics of ictal behavior at the infiltrated margin of glioma BJA Gill, X Wu, FA Khan, AA Sosunov, J Liou, A Dovas, TL Eissa, ... Neurobiology of disease 134, 104676, 2020 | 8 | 2020 |
Single unit analysis and wide-field imaging reveal alterations in excitatory and inhibitory neurons in glioma BJA Gill, FA Khan, AR Goldberg, EM Merricks, X Wu, AA Sosunov, ... Brain 145 (10), 3666-3680, 2022 | 7 | 2022 |
Superficial temporal artery pseudoaneurysm following trigeminal nerve stimulator placement JA Ellis, BJ Gill, D Pisapia, CJ Winfree Neuromodulation 17 (8), 788-790, 2014 | 3 | 2014 |
You're Not Hallucinating: Potential New Targets for Schizophrenia Treatment BJA Gill, FA Khan, GM McKhann Neurosurgery 84 (3), E146-E147, 2019 | 2 | 2019 |
Balloon-and stent-assisted endovascular occlusion of intracranial aneurysms BJA Gill, JA Ellis, PM Meyers Cerebrovascular and Endovascular Neurosurgery: Complication Avoidance and …, 2018 | 2 | 2018 |
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients IY Lee, S Hanft, M Schulder, KD Judy, ET Wong, JB Elder, LT Evans, ... Future Oncology 20 (10), 579-591, 2024 | | 2024 |
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition AR Goldberg, A Dovas, D Torres, S Das Sharma, A Mela, EM Merricks, ... bioRxiv, 2024.01. 10.575092, 2024 | | 2024 |
A randomized, multicenter, double-blind, phase 2b study of IGV-001, an autologous cell immunotherapy with antisense oligo IMV-001 targeting IGF-1R, vs placebo, in newly … I Lee, K Judy, M Schulder, S Hanft, L Evans, J Wu, S Aulakh, E Wong, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |